American Century Companies Inc Vanda Pharmaceuticals Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, American Century Companies Inc holds 294,197 shares of VNDA stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

294,197

Previous 269,971 8.97%

Holding current value

$1.29 Million

Previous $1.53 Million 9.57%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.61 - $6.34 $111,681 - $153,592	24,226 Added 8.97%	294,197 $1.38 Million
Q2 2024 Aug 07, 2024	BUY	$3.91 - $6.5 $73,246 - $121,764	18,733 Added 7.46%	269,971 $1.53 Million
Q1 2024 May 14, 2024	BUY	$3.47 - $4.61 $65,038 - $86,405	18,743 Added 8.06%	251,238 $1.03 Million
Q4 2023 Feb 13, 2024	BUY	$3.38 - $4.58 $785,833 - $1.06 Million	232,495 New	232,495 $981,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $577,894 - $887,094	135,022 Added 164.81%	216,946 $937,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $368,502 - $434,083	62,458 Added 320.86%	81,924 $539,000
Q1 2023 May 11, 2023	SELL	$6.18 - $7.99 $162,206 - $209,713	-26,247 Reduced 57.42%	19,466 $132,000
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $48,090 - $76,720	7,000 Added 18.08%	45,713 $337,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $365,450 - $455,264	38,713 New	38,713 $382,000
Q2 2022 Aug 12, 2022	SELL	$9.31 - $11.84 $514,330 - $654,100	-55,245 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$10.84 - $16.55 $1,528 - $2,333	141 Added 0.26%	55,245 $625,000
Q3 2021 Nov 10, 2021	BUY	$15.35 - $21.27 $11,681 - $16,186	761 Added 1.4%	55,104 $944,000
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $21,002 - $31,738	1,565 Added 2.97%	54,343 $816,000
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $297,730 - $420,845	-30,474 Reduced 36.6%	52,778 $694,000
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $105,325 - $135,838	11,301 Added 15.71%	83,252 $804,000
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $254,164 - $316,258	-26,311 Reduced 26.78%	71,951 $823,000
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $158,520 - $355,084	21,136 Added 27.4%	98,262 $1.02 Million
Q4 2019 Feb 12, 2020	SELL	$12.38 - $17.47 $1.65 Million - $2.33 Million	-133,414 Reduced 63.37%	77,126 $1.27 Million
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $2.58 Million - $3.32 Million	210,540 New	210,540 $2.8 Million
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $1.51 Million - $2.13 Million	-113,208 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$17.59 - $31.05 $19,401 - $34,248	1,103 Added 0.98%	113,208 $0
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $821,894 - $1.36 Million	-43,326 Reduced 27.87%	112,105 $2.93 Million
Q3 2018 Nov 02, 2018	BUY	$18.25 - $23.0 $1.74 Million - $2.19 Million	95,325 Added 158.59%	155,431 $3.57 Million
Q2 2018 Aug 08, 2018	BUY	$13.95 - $19.15 $838,478 - $1.15 Million	60,106 New	60,106 $1.15 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Vanda Pharmaceuticals Inc. Transaction History